Potential Increase in Medicare Prescription Drug Costs for Seniors by 2027

Millions of older adults with Medicare prescription drug coverage might see higher monthly expenses in 2027. The Trump administration will conclude a temporary subsidy program that has helped reduce premiums in recent years. This decision was announced by the Centers for Medicare & Medicaid Services (CMS), highlighting the shift from the initial implementation by the Biden administration in 2024. This program was designed to lower Medicare Part D prescription drug costs in response to the 2022 Inflation Reduction Act.

Federal officials argue the financial impact on Medicare beneficiaries will be minimal. However, this change could have political ramifications in a significant midterm election year. Many voters have expressed concerns about living costs, especially older adults who largely rely on fixed incomes. Approximately 25 million Americans with Medicare Part D plans will be informed about their 2027 rates in the fall, coinciding with the election period.

The decision has faced strong criticism. Senate Minority Leader Chuck Schumer criticized the decision on social media, calling it an active increase in prescription drug costs for seniors. In contrast, CMS Administrator Dr. Mehmet Oz defended the move, stating it would save billions in taxpayer funds by not directing them to insurance companies. He noted that most Medicare beneficiaries might see less than a $10 increase in their monthly premiums, with some experiencing lower premiums. Oz added that Medicare beneficiaries still have access to affordable plans and cited ongoing efforts to reduce prescription drug prices.

Dr. Oz reassured that recent changes do not affect the out-of-pocket cap for standalone Medicare drug coverage. This cap limits annual prescription drug expenses for older adults, remaining at $2,100 in 2026, with a projected increase to $2,400 in 2027. Currently, Medicare Part D beneficiaries pay an average of $36 monthly for prescription drug premiums, with subsidies reducing the average premium by $16, according to the federal Medicare Payment Advisory Commission (MedPAC).

The exact number of Americans affected and potential additional costs remain uncertain. Older Americans regularly choose from a range of plans each year, with prices differing across options. CMS is set to release details about next year’s premiums in September.

Juliette Cubanski, vice president of Medicare policy at KFF, highlighted that while some consumers might face marginal price increases, the cumulative effect when combined with other rising costs could be significant. “What’s going to matter most for consumers is how much more or less they have to pay at the end of a month, and how much they have left after the bills are paid,” she explained. “This could just make it more challenging for some people to make that math work.”